NCT00823407View on ClinicalTrials.gov

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

MDA

subjects will receive a single oral dose of MDA 98mg/70kg body weight

DRUG

Placebo

Subjects will receive a single oral dose of placebo

Trial Locations (1)

94110

CPMC Addiction & Pharmacology Research Laboratory (APRL), San Francisco

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

University of California, San Francisco

OTHER

lead

California Pacific Medical Center Research Institute

OTHER